News for 'Yusuf Hamied'

Cipla promoters to vest voting rights in Yusuf Hamied

The plan was activated in October last year.

Why Cipla's 'successor' decided to quit

A football fan, Kamil Hamied is known to be a calm and quiet person who wants to do something for society, like his uncle Yusuf.

Three Indians who revolutionised medicines in the world

Yusuf Hamied, Anji Reddy and Parvinder Singh are the real pioneers of the Indian pharmaceutical industry.

Cipla heir apparent Kamil steps down

Kamil's elder sister Samina Vaziralli has taken on an expanded role

India's medicine man strikes again

To some -- especially western drug companies -- he is a 'pirate'. To others, mostly those in developing countries, he is an unparalleled hero. Either way, Yusuf Hamied, 75, is perhaps the most talked about man in pharmaceutical circles in the last decade.

'Time has now come to say GOODBYE to India'

Interview with Chairman, Cipla.

Can COVID-19 live in your fridge?

'The majority of transmission will be via people who are within two metres of one another.' 'The closer you are, the more likely that you'll be infected.'

Messiah of the masses: Cipla's global crusade for low cost drugs

Drug maker Cipla always fought a lone battle to make drugs affordable in India.

'Can We In Our Businesses Set An Example?'

'I think some of us, like Mukesh Ambani, myself and those of us who head industrial units, ought to really focus on what we can really do to make the world a safer place, maybe 50 or 100 years from now.' 'For instance, how can we deal with climate change and global warming, right now?' 'The effects of it may not be felt now; in fact, we may pay a price for it today, but it will help the generations to follow.'

14 Indian families in Asia's richest list; Ambanis on 3rd

As many as 14 Indian families have made it to the inaugural list of Forbes' 50 richest families in Asia.

Dilip Shanghvi's X factor shows up in different ways

Dilip Shanghvi has never tried to be everything to everybody.

Cipla's brilliant plan to make it big in the US

Cipla, though late in changing its strategy for international markets, has in recent years taken an inorganic route for expansion.

Cipla opposes Roche flu patent

Crorepati CEO club grew at a slower pace last year

Impact of the slowdown is most visible among promoter/owner-CEOs

'If everyone wore a face mask, this thing will be gone tomorrow!'

'The majority of the spread is by people coughing, or sneezing or talking loudly, in a very short distance, two metres from one another, and a mask will prevent that sort of transmission.'

Billionaire Club: India's 100 richest business tycoons

A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.